China Resources Double-Crane Pharmaceutical Co.,Ltd.

符号: 600062.SS

SHH

23.35

CNY

今天的市场价格

17.5971
市盈率
-0.5329
PEG比率
24.20B
MRK市值
0.01%
DIV收益率

China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062-SS) 财务报表

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 China Resources Double-Crane Pharmaceutical Co.,Ltd. (600062.SS). 的默认数据。公司收入显示 NaN M 的平均值，即 NaN % 增长率。整个期间的平均毛利润为 NaN M，即 NaN %. 平均毛利率为 NaN %. 公司去年的净收入增长率为 NaN %，等于 NaN % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 China Resources Double-Crane Pharmaceutical Co.,Ltd. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为. 回顾过去一年，总资产变化为 NaN. 股东权益总额所体现的股东价值是以报告货币计算的 NaN. 这方面的年同比变化率为 NaN%.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
balance-sheet.row.cash-and-short-term-investments	3457	2830.7	3637.6	3262.2	2602.1	1975.7	1248.1	1486.9	778.2	1366.3	1410	1004.7	1104.5	1056.6	1023.5	1028.4	654.3	452	668.7	573.7	444.7	513.7	555.3	302.8	318.7	140.7	337.9	9.2	14.3	1.1
balance-sheet.row.short-term-investments	240.7	200.5	803.6	851.9	758.1	878.7	-18	-33.2	-42.6	-31.4	0	0	0	0	0	0	0	0	0.1	0	0	0	0	98.4	0	0	0	0	0	0
balance-sheet.row.net-receivables	2403.5	2362.8	2127	2216.7	2130.9	2017.5	1892.7	1864.7	1737.4	1386.6	1886.8	1969.7	1849.3	1408.8	1239.8	1012.2	1358.8	971.1	1095.3	1209.3	1378.7	1197.8	720.6	44.7	37.8	39.6	86.3	23.4	67.9	76.3
balance-sheet.row.inventory	1562.4	1878.6	1665.5	1289.3	1146	973.6	974.2	762.8	808.7	653.7	566.1	779.1	701	709.9	600.1	604.5	528.6	466.5	507.3	485.2	563.6	584.7	407.4	174.5	141.5	117.3	30.2	36.5	0	1.8
balance-sheet.row.other-current-assets	215.5	92.8	92.5	32	159.7	168.4	665.1	191.4	435	514.4	18.2	138	42.2	18.2	6.2	37.3	-231	-69.9	-137.1	-129.7	-72.7	-115	0.5	294.9	210.2	79.3	-26.2	-8.3	-3.2	-2.9
balance-sheet.row.total-current-assets	7638.5	7165	7522.6	6800.3	6038.7	5135.2	4780.2	4305.8	3759.3	3921.1	3881.2	3891.6	3697	3193.5	2869.6	2682.5	2310.6	1819.6	2134.1	2138.5	2314.2	2181.2	1683.8	816.9	708.3	376.9	428.2	60.8	79	76.3
balance-sheet.row.property-plant-equipment-net	3852.5	3506.6	2957.1	2673	2621.8	2632.5	2449.6	2361.4	2444.2	2053.6	2017.5	2027.8	1827.4	1563.2	1432.5	1223.9	997.8	1274.6	1504.9	1552.1	1538.7	1120.4	912.9	452.4	336.9	236	123.7	93.5	53.3	55
balance-sheet.row.goodwill	906.1	935	788.2	796.4	839.8	864.4	797	391.7	391.7	109.5	109.5	110.3	66.6	9.1	9.1	9.1	0.8	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	2482.3	2281	1899.5	1650.7	1637.4	1525.6	1315.8	1031.9	978	385.4	384.7	343	307.9	233.1	201.7	147.8	163.6	52.2	53.3	74.9	78.5	75.9	45.2	60.3	61.6	67.5	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	3388.3	3216	2687.7	2447.1	2477.2	2390	2112.8	1423.6	1369.7	494.9	494.2	453.3	374.5	242.2	210.7	156.9	164.4	52.2	53.3	74.9	78.5	75.9	45.2	60.3	61.6	67.5	0	0	0	0
balance-sheet.row.long-term-investments	403.1	149.8	-500.2	-481.9	-723.9	-855.9	20.1	49.7	64.3	53	0	0	0	0	0	0	0	0	109.6	0	0	0	98.7	40.7	0	0	0	0	0	0
balance-sheet.row.tax-assets	192	124.7	73.8	52.2	50.3	53.5	50.2	42.8	29.2	27.7	29.9	21.7	23.6	27.2	27	24.6	14.3	0	0	0	0	0	5.7	111.5	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	22.1	320.6	935.1	925.7	812.7	951	24.9	58.3	96.5	68.9	58.1	113.5	154.4	179.4	177.1	181.2	186.3	112.9	11.4	259.7	326.4	239	0	2.4	78	60.6	22.8	0	0	0
balance-sheet.row.total-non-current-assets	7858	7317.6	6153.5	5616.2	5238.2	5171	4657.7	3935.8	4003.8	2698.2	2599.7	2616.2	2380	2012.1	1847.4	1586.6	1362.8	1439.7	1679.2	1886.7	1943.6	1435.3	1062.5	667.3	476.6	364.1	146.5	93.5	53.3	55
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	15496.5	14482.5	13676.1	12416.5	11276.9	10306.2	9437.9	8241.5	7763.1	6619.3	6480.9	6507.8	6077	5205.5	4717	4269	3673.5	3259.3	3813.3	4025.3	4257.9	3616.5	2746.3	1484.2	1184.8	741	574.7	154.3	132.3	131.3
balance-sheet.row.account-payables	696.7	744.5	847.4	848	690.8	547.3	469.2	395.7	400.7	488.4	428.5	959.9	718.3	568.3	518.1	440.5	593	624.2	745.1	924.6	1041.8	829.2	499.7	192.8	116.4	33.1	19.6	8.2	11.5	18
balance-sheet.row.short-term-debt	432.9	32.1	29.5	6.6	64.9	75	0	0	30	0	210	295	400.7	279.4	278	341.5	311	318.5	717.8	885.4	875.8	697.9	374.5	249.3	186.6	106	75	31.5	0.4	0
balance-sheet.row.tax-payables	65.7	201.7	138.9	122.6	131.3	153.6	113.9	108.7	121.4	68.2	112.3	62.9	150.7	68.7	55.7	60.9	120.3	65.2	101.4	113.6	94.6	131.3	84.9	69.9	41.2	21.3	2.4	-0.2	0	0
balance-sheet.row.long-term-debt-total	29.9	232.9	35.4	151	0.5	7	1.5	1.5	11.2	1.2	0	0	0	13.4	0	0	16	23	4.1	4.1	204	8.6	52	1	2.3	10	0	4	0	0
Deferred Revenue Non Current	180.6	198.8	153.8	100.9	97.8	113.8	108.2	111.4	132.7	108.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	1822.3	2042.3	57.2	43.9	43.9	1352.2	739.9	619.6	120.4	337.9	89.6	65.9	59.6	52	43.8	29.3	68.8	31.4	55.8	38.1	43.6	49	32.1	18.2	35.7	0.7	0	2.6	3.5	18.4
balance-sheet.row.total-non-current-liabilities	364	741.1	468.6	369.5	258.9	269.6	380.2	187.8	224.9	108.6	115.8	118.7	81.8	89.5	54.1	41.3	52.2	29.9	52.4	65.5	264.7	45.9	106.3	6.7	7.2	11	0	4	0	0
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	29.9	32.9	35.4	121.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	3526.1	3752.9	3199.5	3039.5	2600.3	2397.6	1589.3	1203.1	1329.2	934.9	1144.7	1801	1733.7	1279.6	1182.2	1118.6	1308.8	1264.1	1874	2297.9	2541.2	2011.6	1256.3	628.9	473.6	199.6	101.8	48.5	29.2	36.4
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	1039.7	1043.2	1043.2	1043.2	1043.2	1043.2	869.4	724.5	724.5	571.7	571.7	571.7	571.7	571.7	571.7	476.4	441.1	441.1	441.1	441.1	441.1	441.1	339.3	305.7	235.2	147	147	88	86.8	86.8
balance-sheet.row.retained-earnings	9670.6	8560.9	8196.4	7580.1	6892.1	6186.8	5517.4	4939.2	4374.9	3643.3	3296.9	2610.9	2216	1867.4	1511.8	1249.4	980.8	527	462.5	326.3	289	244.3	171.4	132.8	71.9	86.5	38	4.5	1.9	1.9
balance-sheet.row.accumulated-other-comprehensive-income-loss	380	594.3	561.9	566.8	563.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	0	-175.7	103.9	103.9	103.9	609.9	1070	1022.5	1007.2	1464.1	1464.1	1471	1470	1424.1	1387.1	1353.7	775.6	847.5	824.3	771	761.7	718.8	772	352.1	385.2	300.5	287.9	13.3	14.4	6.2
balance-sheet.row.total-stockholders-equity	11090.4	10022.6	9905.5	9294.1	8602.5	7839.9	7456.8	6686.2	6106.7	5679.1	5332.7	4653.6	4257.7	3863.2	3470.5	3079.5	2197.5	1815.5	1727.9	1538.4	1491.8	1404.2	1282.8	790.6	692.2	534	472.9	105.8	103.1	94.9
balance-sheet.row.total-liabilities-and-stockholders-equity	15496.5	14482.5	13676.1	12416.5	11276.9	10306.2	9437.9	8241.5	7763.1	6619.3	6480.9	6507.8	6077	5205.5	4717	4269	3673.5	3259.3	3813.3	4025.3	4257.9	3616.5	2746.3	1484.2	1184.8	741	574.7	154.3	132.3	131.3
balance-sheet.row.minority-interest	699.4	707	571.1	82.9	74.1	68.7	391.8	352.3	327.2	5.2	3.5	53.1	85.6	62.8	64.3	70.9	167.2	179.7	211.4	188.9	224.8	200.7	207.2	64.7	19	7.5	0	0	0	0
balance-sheet.row.total-equity	11789.8	10729.6	10476.6	9377	8676.6	7908.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	643.8	350.3	303.4	370.1	34.3	22.8	2.1	16.5	21.7	21.6	26.7	26.7	64.1	85.3	83.4	81.5	82.9	103.4	109.7	252.2	325.6	194.5	98.7	139.1	70.1	53.2	0	0	0	0
balance-sheet.row.total-debt	462.9	265	64.9	6.6	64.9	82	0	0	41.2	1.2	210	295	400.7	292.8	278	341.5	311	318.5	721.9	889.5	1079.7	706.4	426.5	250.3	188.9	116	75	35.5	0.4	0
balance-sheet.row.net-debt	-2753.4	-2365.3	-2769.1	-2403.6	-1779.1	-1015.1	-1248.1	-1486.9	-737	-1365.1	-1200	-709.7	-703.8	-763.8	-745.5	-686.9	-343.3	-133.5	53.3	315.9	635	192.7	-128.8	45.9	-129.9	-24.7	-262.9	26.3	-13.9	-1.1

现金流量表

在 China Resources Double-Crane Pharmaceutical Co.,Ltd. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 NaN 的转变。该公司最近通过发行 NaN 扩大了股本，与上一年相比出现了NaN 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到NaN. 与上一年相比， NaN 发生了变化. 在同一时期，公司记录了 NaN, NaN 和 NaN，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为NaN，同比差异为NaN. 此外，公司还将NaN 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 NaN，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998
cash-flows.row.net-income	1333	1215.4	972.1	1013.5	1066.5	989.5	882.1	739.2	664.8	543.7	873.4	630.5	552.5	533	463.5	396.5	457.6	179.2	190	-25.4	51.6	146.2	162	138.6	75.3	61.1
cash-flows.row.depreciation-and-amortization	655.5	540.6	465	371.7	357.4	343.7	335.8	313.7	269.3	235.6	267.7	214.8	176.4	157.9	135.5	126.4	105.7	99.7	118.3	123.6	101.4	89.6	79.2	43.1	62.6	12.7
cash-flows.row.deferred-income-tax	-18.1	-20.7	-23.8	-3.1	-3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	-1705.5	36	23.8	3.1	3.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-412.6	-413.5	-143.5	-62.4	-31.3	152.6	-35.3	-276.3	-213.7	-65.7	-368.2	-459.9	-244.8	-202.8	-214.2	-244.3	-197	-119.4	-227.4	103.3	-196.3	-145	-166.8	-26.1	-27.4	-93.2
cash-flows.row.account-receivables	-488.7	-266.2	-130.7	-216.2	-369.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	315.7	-34.3	-384.5	-146.8	-185.1	-4.9	-202.9	31.6	33.5	-85.2	-46.2	-78.1	18.8	-111.8	11.4	-104.9	-64.1	-14.1	-55	75.8	64.8	-58.4	-74.5	-33	-27.9	-87.1
cash-flows.row.account-payables	-221.6	-92.2	395.5	303.6	526.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	-18	-20.7	-23.8	-3.1	-3.2	157.5	167.5	-307.9	-247.2	19.5	-321.9	-381.8	-263.6	-91.1	-225.6	-139.4	-133	-105.3	-172.4	27.5	-261.1	-86.6	-92.3	7	0.6	-6.1
cash-flows.row.other-non-cash-items	1798.5	-16.1	47.2	37.3	47.3	-16.8	4.5	-5.4	-19.1	4.7	-226.7	10.5	27.4	21.6	-42.7	53.2	-130.8	144.2	59	252.2	192.3	49.9	66.6	17.2	21.1	5.6
cash-flows.row.net-cash-provided-by-operating-activities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-604.5	-525.5	-491.7	-348.1	-241.6	-228.7	-154.8	-110	-168.5	-142.4	-217.7	-221.9	-338.8	-370.2	-285.2	-309.2	-136.2	-171.7	-127.1	-196.8	-376	-252	-175.6	-86.8	-69.9	-130.3
cash-flows.row.acquisitions-net	-127.2	-409.2	36.6	42.7	-112.8	-257.7	-648.2	1.2	-697.1	149.4	194	-111.3	-50.3	0	0	0	171.8	41.6	12.8	0	43.5	2.2	4.8	0.2	0	0
cash-flows.row.purchases-of-investments	-2340	-1350	-3199.9	-2421.4	-3064.1	-2019.7	-1290.8	-735	-2607.5	-1280	-2.9	-4.6	-76.5	0	6.8	0	-24.1	-10.8	-15.7	0	-152.7	-55.7	-59.4	-169.3	-30	-26.8
cash-flows.row.sales-maturities-of-investments	2303	2951.7	3051.7	2296	2342.7	1678.7	864.9	1003	2723.7	898.6	119	94.9	55.8	0	2.8	1.2	2	45.4	261.6	11.7	4.5	2.1	103.7	5.7	1	0
cash-flows.row.other-investing-activites	60.9	-0.2	33.4	12.9	6.5	4	96.4	4.2	39.2	22	6.4	34.6	5.7	62.4	43.9	138.1	13	7.7	-21.9	32.7	7.8	-1.3	53.2	-2	0	12.9
cash-flows.row.net-cash-used-for-investing-activites	-707.8	666.8	-569.8	-418	-1069.3	-823.5	-1132.5	163.3	-710.1	-352.3	98.9	-208.3	-404.2	-307.8	-231.6	-170	26.6	-87.9	109.7	-152.4	-472.9	-304.7	-73.3	-252.2	-98.8	-144.2
cash-flows.row.debt-repayment	-9.3	-6.2	-47.7	-64.3	-306.9	-36.6	0	-40	-182.9	-210	-265	-694.8	-595.3	-283.8	-470.8	-350.3	-314.5	-689.3	-895.3	-983.1	-1113.8	-635.7	-576.7	-358.5	-224.9	-173.6
cash-flows.row.common-stock-issued	-29.7	144.7	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	-1	-290.9	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-300.5	-801.8	-302.6	-319.3	-299.2	-91.1	-193.7	-184.7	-3.4	-199.7	-217.2	-250.8	-155	-145.7	-79.9	-111.3	-93.2	-106.4	-43.9	-48.1	-89.1	-68	-56.2	-41.6	0	-8.9
cash-flows.row.other-financing-activites	-17.8	-337	-28.3	-2.5	81.2	-675.4	-99.7	0	-397.7	0	371.5	613.4	694.5	275.5	386.4	723.7	304.6	392.3	775.9	858.8	1457.9	826.1	915.9	365.2	370.2	143.2
cash-flows.row.net-cash-used-provided-by-financing-activities	-358.3	-1291.2	-378.6	-386.2	-524.9	-803.1	-293.5	-224.7	-583.9	-409.7	-110.7	-332.3	-55.8	-154	-164.3	262.2	-103.1	-403.4	-163.3	-172.4	255	122.4	283.1	-34.9	145.3	-39.3
cash-flows.row.effect-of-forex-changes-on-cash	3.7	12.3	1.3	-0.1	0	0	-0.1	0	0.1	0	-0.4	-0.1	0.8	0	0	0	0.1	0.4	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	585.8	729.6	393.8	555.9	-154.4	-157.5	-238.9	709.9	-592.5	-43.7	534	-144.5	52.3	47.9	-53.9	423.9	159.1	-187.1	86.1	129	-69	-41.6	350.8	-114.3	178.1	-197.2
cash-flows.row.cash-at-end-of-period	3216.3	2614.7	1885.1	1491.3	935.4	1089.8	1247.3	1486.2	776.3	1366.3	1410	876	1020.6	968.2	920.3	974.2	550.3	375	562.1	573.7	444.7	513.7	555.3	204.5	318.7	140.7
cash-flows.row.cash-at-beginning-of-period	2630.4	1885.1	1491.3	935.4	1089.8	1247.3	1486.2	776.3	1368.8	1410	876	1020.6	968.3	920.3	974.2	550.3	391.2	562.1	476	444.7	513.7	555.3	204.5	318.7	140.7	337.9
cash-flows.row.operating-cash-flow	1650.8	1341.7	1340.9	1360.2	1439.8	1469	1187.1	771.2	701.3	718.4	546.2	396	511.5	509.7	342	331.7	235.5	303.7	139.8	453.7	148.9	140.6	141	172.8	131.5	-13.8
cash-flows.row.capital-expenditure	-604.5	-525.5	-491.7	-348.1	-241.6	-228.7	-154.8	-110	-168.5	-142.4	-217.7	-221.9	-338.8	-370.2	-285.2	-309.2	-136.2	-171.7	-127.1	-196.8	-376	-252	-175.6	-86.8	-69.9	-130.3
cash-flows.row.free-cash-flow	1046.3	816.1	849.2	1012.1	1198.1	1240.3	1032.3	661.2	532.9	576	328.6	174.2	172.7	139.5	56.9	22.5	99.3	132.1	12.6	256.9	-227	-111.4	-34.6	86	61.7	-144.1

利润表行

China Resources Double-Crane Pharmaceutical Co.,Ltd. 的收入与上期相比变化了 NaN%。据报告, 600062.SS 的毛利润为 NaN。该公司的营业费用为 NaN，与上年相比变化了 NaN%. 折旧和摊销费用为 NaN，与上一会计期间相比变化了 NaN%. 营业费用报告为 NaN，显示NaN% 的同比变化。销售和营销费用为 NaN, 其中 NaN% 与上年相比发生了变化。基于近期数据的EBITDA为 NaN，同比增长NaN%. 营业收入为 NaN，与上年相比变化了NaN%. 净利润的变化率为 NaN%。去年的净收入为NaN.

common:word.in-mln USD Growth	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004	2002	2000	1998	1996	1994
income-statement-row.row.total-revenue	10089.3	9446.9	9111.5	8503.9	9381	8225.1	6421.8	5494.8	5138.4	4281	6834.6	6989.3	6383.4	5366.8	5037.9	4951.5	4556.6	4049.1	4597.4	4195.7	4249.2	3686.3	2382.7	1168.3	723.2	350.7	236.3	208.4	168.1	156.7
income-statement-row.row.cost-of-revenue	4948.2	4231.8	4030	3145.2	3430.6	3014.4	2733.7	2576.5	2473.1	2206	4470	4661.5	4321.5	3424.9	3327.6	3417.7	3186.3	2902.8	3365.2	3085.9	3096.8	2544.8	1500.4	634	447.5	227.2	160.9	131.1	103.4	107
income-statement-row.row.gross-profit	5141.2	5215.1	5081.5	5358.7	5950.3	5210.7	3688.1	2918.3	2665.3	2075	2364.6	2327.9	2061.9	1941.9	1710.4	1533.8	1370.4	1146.3	1232.3	1109.8	1152.4	1141.5	882.2	534.4	275.6	123.4	75.4	77.3	64.7	49.7
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-14.5	639.7	612.8	682.9	589.3	-5.2	-6.4	69.3	49.5	27.5	33.3	33	62.5	31.4	22.9	18.6	180.9	48.6	-16.2	12.1	20.3	21.1	19.8	11.3	16.5	12.6	4.4	0	0	0.6
income-statement-row.row.operating-expenses	3684.5	3901.5	3978.5	4121.8	4645.2	4031.3	2612.3	2060.8	1918.6	1453.1	1561.8	1613.5	1412.5	1335.3	1163.9	1071.9	913.5	920.4	1017.2	996.7	972.3	932.6	684.3	355.9	173.9	54.6	27.6	23.7	16.7	14.1
income-statement-row.row.cost-and-expenses	8632.6	8133.4	8008.5	7267	8075.8	7045.7	5346.1	4637.3	4391.8	3659	6031.7	6275	5734	4760.2	4491.5	4489.6	4099.7	3823.1	4382.3	4082.6	4069.1	3477.4	2184.7	989.9	621.4	281.8	188.5	154.8	120.1	14.1
income-statement-row.row.interest-income	52.9	88.5	54.4	48.5	20.3	12	10.9	9.7	26.8	24.4	16.8	12.8	12.2	5.8	5.1	0	0	7.7	15	4.8	5.3	9	3.8	3	0	0	0	0	0	0
income-statement-row.row.interest-expense	15.4	10.6	11.6	3.7	9.5	8.2	0	2.4	6.5	4.7	22.5	24.2	23.5	12.5	14.5	12.8	11.4	27	49.4	46.8	48.4	37.3	28.2	18.1	12	-3.5	-0.8	3	3.8	3.9
income-statement-row.row.selling-and-marketing-expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	97.3	8.5	-15.8	-14.2	-0.7	4.8	-21.8	49.3	60.1	36.5	263.9	48.4	53.6	10.3	15	8.8	117.8	9.5	12.4	-99.2	-104.7	-27	-20	-6	-2.2	14.5	5.1	-3	-3.8	-3.9
income-statement-row.row.ebitda-ratio-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-14.5	639.7	612.8	682.9	589.3	-5.2	-6.4	69.3	49.5	27.5	33.3	33	62.5	31.4	22.9	18.6	180.9	48.6	-16.2	12.1	20.3	21.1	19.8	11.3	16.5	12.6	4.4	0	0	0.6
income-statement-row.row.total-operating-expenses	97.3	8.5	-15.8	-14.2	-0.7	4.8	-21.8	49.3	60.1	36.5	263.9	48.4	53.6	10.3	15	8.8	117.8	9.5	12.4	-99.2	-104.7	-27	-20	-6	-2.2	14.5	5.1	-3	-3.8	-3.9
income-statement-row.row.interest-expense	15.4	10.6	11.6	3.7	9.5	8.2	0	2.4	6.5	4.7	22.5	24.2	23.5	12.5	14.5	12.8	11.4	27	49.4	46.8	48.4	37.3	28.2	18.1	12	-3.5	-0.8	3	3.8	3.9
income-statement-row.row.depreciation-and-amortization	655.5	582.3	491	444.5	427.3	343.7	335.8	313.7	269.3	235.6	267.7	214.8	176.4	157.9	135.5	126.4	105.7	99.7	118.3	123.6	101.4	89.6	79.2	43.1	62.6	12.7	-1	3	3.8	-45.8
income-statement-row.row.ebitda-caps	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	1456.7	1406.1	1136.9	1229.3	1262.5	1189.3	1060.4	843.2	764.3	638.4	1033.9	731.3	655.2	592.7	542.2	452	393.8	222.1	270	29.9	116.7	208.2	189	175.1	93.2	73.5	48.9	50.7	44.2	31.7
income-statement-row.row.income-before-tax	1554	1414.6	1121.2	1215	1261.8	1184.1	1053.9	906.8	806.8	658.4	1066.8	762.8	703	616.9	561.4	470.7	574.7	253.1	240.7	28	106.2	205.6	193.4	179.4	104.6	84.7	53.1	50.7	44.2	31.7
income-statement-row.row.income-tax-expense	240.6	199.3	149.1	201.5	195.3	194.7	171.8	167.5	141.9	114.7	193.3	132.2	150.5	83.9	98	74.2	117.1	67.5	51.9	53.4	54.7	59.4	31.3	40.8	29.4	23.6	5.5	-3	0.2	0.2
income-statement-row.row.net-income	1333	1180.1	935.7	1005.2	1055.1	968.6	842.6	714.2	661.1	541.9	870.7	614.4	529	520.1	451.5	380.6	437.6	164.9	186.6	4.7	64.6	168.4	157.7	128.9	75.9	60.9	47.5	50.7	44	31.5